Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

9.98USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$9.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.66

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.60 -0.869
Jun '17
FY 2016 Dec '16 0.34 -0.600
Sep '16 0.00 -0.533
Jun '16
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.50 1.00 0.00 --
Quarter Ending Jun-18 2 0.10 0.20 0.00 --
Year Ending Dec-18 5 4.88 11.40 0.00 --
Earnings (per share)
Quarter Ending Mar-18 3 -1.35 -0.80 -2.34 --
Quarter Ending Jun-18 3 -1.30 -0.96 -1.94 --
Year Ending Dec-18 5 -5.21 -3.11 -7.75 --
LT Growth Rate (%) 1 0.60 0.60 0.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. -- 285.47 45.93
P/E Low - Last 5 Yrs. -- 93.40 24.19
Beta -- 0.81 0.81
Price to Sales (TTM) 108.56 137.31 8.08
Price to Book (MRQ) -- 20.28 5.24
Price to Tangible Book (MRQ) 6.00 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions 46.29 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 62.55 7.61
Sales - 5 Yr. Growth Rate -- 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -62.97 -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 3.92 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.26 12.18
Total Debt to Equity (MRQ) 0.00 18.35 15.60
Interest Coverage (TTM) -- -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -2,737.40 -- --
EBITD - 5 Yr. Avg -- -233.45 14.67
Operating Margin (TTM) -2,766.09 -490.18 4.40
Operating Margin - 5 Yr. Avg. -- -250.27 9.99
Pre-Tax Margin (TTM) -2,590.08 -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -- -256.86 10.24
Net Profit Margin (TTM) -2,590.08 -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -- -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,552 23,887,942 823,803,020
Net Income/Employee (TTM) -1,179,828 -537,326 96,327,335
Receivable Turnover (TTM) -- 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) -- 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.02 10.76
Return on Assets - 5 Yr. Avg. -- -0.09 12.05
Return on Investment (TTM) -- -0.67 13.67
Return on Investment - 5 Yr. Avg. -- 2.39 15.78
Return on Equity (TTM) -- -3.38 15.40
Return on Equity - 5 Yr. Avg. -- -1.61 17.04
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -122.89 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spero Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -17.52 -13.39 17 72
13 Week -27.15 -30.03 13 94
26 Week -- -- -- 89
52 Week -- -- -- 90
YTD -15.06 -16.02 22 92
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.30%
# of Holders: 46
Total Shares Held: 6,652,331
3 Mo. Net Change: 6,606,886
# New Positions: 43
# Closed Positions: 0
# Increased Positions: 45
# Reduced Positions: 1
# Net Buyers: 44
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.